📰 Industry Classification Benchmark News
Page 3 - Industry Classification Benchmark News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Industry Classification Benchmark. Real-time updates on events, politics, business and more.
April 20, 2024
John G Ullman & Associates Inc. decreased its holdings in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 38.2% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,700 shares of the financial services provider’s stock after selling 1,050 shares during the quarter. […]
April 11, 2024
Sandy Spring Bank raised its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 1.3% in the 4th quarter, Holdings Channel reports. The firm owned 30,566 shares of the financial services provider’s stock after purchasing an additional 397 shares during the quarter. Sandy Spring Bank’s holdings in iShares Biotechnology ETF were worth […]
April 11, 2024
Sandy Spring Bank raised its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 1.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,566 shares of the financial services provider’s stock after buying an additional 397 shares during […]
April 4, 2024
Carmichael Hill & Associates Inc. increased its stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 52.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 608 shares of the financial services provider’s stock after buying an additional 209 shares during the period. Carmichael Hill & Associates Inc.’s holdings in iShares Biotechnology ETF were […]
April 4, 2024
Carmichael Hill & Associates Inc. lifted its position in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 52.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 608 shares of the financial services provider’s stock after buying an additional 209 shares during […]
April 4, 2024
Camelot Portfolios LLC acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 1,833 shares of the financial services provider’s stock, valued at approximately $249,000. Other large investors also recently […]
April 2, 2024
ABN AMRO Bank N.V. SASB Content Index 2023 - Commercial Banking Standard Disclosure Topic ...
March 29, 2024
Clear Harbor Asset Management LLC reduced its stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 21.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,693 shares of the financial services provider’s stock after selling 996 […]
March 27, 2024
Bar Harbor Wealth Management grew its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 1.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 14,610 shares of the financial services provider’s stock after buying an additional 153 shares […]
March 27, 2024
Bar Harbor Wealth Management boosted its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 1.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 14,610 shares of the financial services provider’s stock after purchasing an additional 153 shares […]